| __timestamp | Apellis Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 1488000000 |
| Thursday, January 1, 2015 | 13730311 | 1525000000 |
| Friday, January 1, 2016 | 22978599 | 2111000000 |
| Sunday, January 1, 2017 | 40303878 | 1848000000 |
| Monday, January 1, 2018 | 105285576 | 1213000000 |
| Tuesday, January 1, 2019 | 220968770 | 1010000000 |
| Wednesday, January 1, 2020 | 299921000 | 997000000 |
| Friday, January 1, 2021 | 420869000 | 967000000 |
| Saturday, January 1, 2022 | 387236000 | 838000000 |
| Sunday, January 1, 2023 | 354387000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unleashing insights
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Apellis Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. Teva, a global leader, consistently allocated substantial resources, peaking in 2016 with a 63% increase from 2014. However, their R&D spending saw a gradual decline, dropping by 55% by 2023. In contrast, Apellis, a rising star, showcased a remarkable growth trajectory. From 2014 to 2021, their R&D expenses surged by an impressive 4,900%, reflecting their commitment to pioneering treatments. By 2023, Apellis's R&D spending was nearly 42% of Teva's, highlighting their rapid ascent in the industry. This data underscores the dynamic nature of pharmaceutical innovation, where strategic R&D investments can redefine market positions.
Research and Development Expenses Breakdown: Bristol-Myers Squibb Company vs Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Insmed Incorporated
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Pharming Group N.V.
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Grifols, S.A.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Alkermes plc
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs MiMedx Group, Inc.
Apellis Pharmaceuticals, Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.